Header Logo

Connection

Cynthia Firnhaber to Female

Back to Details
This is a "connection" page, showing publications Cynthia Firnhaber has written about Female.
Cynthia Firnhaber
Connection Strength
1,726
Female
  1. Mammogram and Pap Smear Uptake Among Women in the HIV Outpatient Study USA, 2010-2021. AIDS Patient Care STDS. 2024 04; 38(4):151-154.
    View in: PubMed
    Score: 0,088
  2. Human Papillomavirus Vaccination Prior to Loop Electroexcision Procedure Does Not Prevent Recurrent Cervical High-grade Squamous Intraepithelial Lesions in Women Living With Human Immunodeficiency Virus: A Randomized, Double-blind, Placebo-controlled Trial. Clin Infect Dis. 2021 10 05; 73(7):e2211-e2216.
    View in: PubMed
    Score: 0,074
  3. Delay to diagnosis and breast cancer stage in an urban South African breast clinic. S Afr Med J. 2019 Feb 26; 109(3):159-163.
    View in: PubMed
    Score: 0,062
  4. Unraveling the South African Breast Cancer Story: The Relationship of Patients, Delay to Diagnosis, and Tumor Biology With Stage at Presentation in an Urban Setting. J Surg Res. 2019 03; 235:181-189.
    View in: PubMed
    Score: 0,060
  5. The Effect of Access to Information on Beliefs Surrounding Breast Cancer in South Africa. J Cancer Educ. 2018 08; 33(4):806-813.
    View in: PubMed
    Score: 0,059
  6. Cryotherapy Reduces Progression of Cervical Intraepithelial Neoplasia Grade 1 in South African HIV-Infected Women: A Randomized, Controlled Trial. J Acquir Immune Defic Syndr. 2017 Dec 15; 76(5):532-538.
    View in: PubMed
    Score: 0,057
  7. A randomized clinical trial comparing cervical dysplasia treatment with cryotherapy vs loop electrosurgical excision procedure in HIV-seropositive women from Johannesburg, South Africa. Am J Obstet Gynecol. 2017 Aug; 217(2):183.e1-183.e11.
    View in: PubMed
    Score: 0,054
  8. Characterizing breast conditions at an open-access breast clinic in South Africa: a model that is more than cancer care for a resource-limited setting. BMC Health Serv Res. 2017 01 21; 17(1):63.
    View in: PubMed
    Score: 0,053
  9. HPV vaccination in Southern Africa: A jab of hope in the fight against cervical cancer. Cancer Cytopathol. 2016 10; 124(10):695-698.
    View in: PubMed
    Score: 0,051
  10. A call to action: Addressing the reproductive health needs of women with drug-resistant tuberculosis. S Afr Med J. 2016 Mar 17; 106(4):30-1.
    View in: PubMed
    Score: 0,050
  11. Xpert human papillomavirus test is a promising cervical cancer screening test for HIV-seropositive women. Papillomavirus Res. 2016 Dec; 2:56-60.
    View in: PubMed
    Score: 0,050
  12. Prospective One Year Follow Up of HIV Infected Women Screened for Cervical Cancer Using Visual Inspection with Acetic Acid, Cytology and Human Papillomavirus Testing in Johannesburg South Africa. PLoS One. 2016; 11(1):e0144905.
    View in: PubMed
    Score: 0,050
  13. Cost-effectiveness of using the Cervex-Brush (broom) compared to the elongated spatula for collection of conventional cervical cytology samples within a high-burden HIV setting: a model-based analysis. BMC Health Serv Res. 2015 Nov 06; 15:499.
    View in: PubMed
    Score: 0,049
  14. Differences in antiretroviral safety and efficacy by sex in a multinational randomized clinical trial. HIV Clin Trials. 2015 May-Jun; 16(3):89-99.
    View in: PubMed
    Score: 0,047
  15. Reply to letter to the editor by Sue J. Goldie and Phil E. Castle regarding Evaluation of a cervicography-based program to ensure visual inspection of the cervix in HIV-infected women in Johannesburg, South Africa by Firnhaber et al. J Low Genit Tract Dis. 2015 Apr; 19(2):e46-7.
    View in: PubMed
    Score: 0,047
  16. Cost evaluation of reproductive and primary health care mobile service delivery for women in two rural districts in South Africa. PLoS One. 2015; 10(3):e0119236.
    View in: PubMed
    Score: 0,047
  17. Evaluation of a cervicography-based program to ensure quality of visual inspection of the cervix in HIV-infected women in Johannesburg, South Africa. J Low Genit Tract Dis. 2015 Jan; 19(1):7-11.
    View in: PubMed
    Score: 0,046
  18. Injectable and oral contraception and the incidence and progression of cervical disease in HIV-infected women in South Africa. Contraception. 2014 Apr; 89(4):286-91.
    View in: PubMed
    Score: 0,043
  19. Validation of cervical cancer screening methods in HIV positive women from Johannesburg South Africa. PLoS One. 2013; 8(1):e53494.
    View in: PubMed
    Score: 0,040
  20. Human papillomavirus vaccines: where do they fit in HIV-infected individuals? Curr HIV/AIDS Rep. 2012 Sep; 9(3):278-86.
    View in: PubMed
    Score: 0,039
  21. Urethritis/cervicitis pathogen prevalence and associated risk factors among asymptomatic HIV-infected patients in South Africa. Sex Transm Dis. 2012 Jul; 39(7):531-6.
    View in: PubMed
    Score: 0,039
  22. Highly active antiretroviral therapy and cervical dysplasia in HIV-positive women in South Africa. J Int AIDS Soc. 2012 Jun 07; 15(2):17382.
    View in: PubMed
    Score: 0,039
  23. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected women from South Africa, Brazil and Botswana. J Clin Virol. 2011 Nov; 52(3):265-8.
    View in: PubMed
    Score: 0,037
  24. Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas. Int J Infect Dis. 2010 Dec; 14(12):e1088-92.
    View in: PubMed
    Score: 0,035
  25. Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa. Cancer Causes Control. 2010 Mar; 21(3):433-43.
    View in: PubMed
    Score: 0,032
  26. Diverse and high prevalence of human papillomavirus associated with a significant high rate of cervical dysplasia in human immunodeficiency virus-infected women in Johannesburg, South Africa. Acta Cytol. 2009 Jan-Feb; 53(1):10-7.
    View in: PubMed
    Score: 0,030
  27. The prevalence of hepatitis B co-infection in a South African urban government HIV clinic. S Afr Med J. 2008 Jul; 98(7):541-4.
    View in: PubMed
    Score: 0,029
  28. Extensive cervical lesion and treatment outcomes in women with HIV/HPV co-infection. AIDS Res Ther. 2024 Dec 30; 21(1):101.
    View in: PubMed
    Score: 0,023
  29. A Semimechanistic Pharmacokinetic Model for Depot Medroxyprogesterone Acetate and Drug-Drug Interactions With Antiretroviral and Antituberculosis Treatment. Clin Pharmacol Ther. 2021 10; 110(4):1057-1065.
    View in: PubMed
    Score: 0,018
  30. Pharmacokinetics and Pharmacodynamics of Depot Medroxyprogesterone Acetate in African Women Receiving Treatment for Human Immunodeficiency Virus and Tuberculosis: Potential Concern for Standard Dosing Frequency. Clin Infect Dis. 2020 07 27; 71(3):517-524.
    View in: PubMed
    Score: 0,017
  31. A Pooled Analysis to Compare the Clinical Characteristics of Human Papillomavirus-positive and -Negative Cervical Precancers. Cancer Prev Res (Phila). 2020 10; 13(10):829-840.
    View in: PubMed
    Score: 0,017
  32. Gene expression profiling informs HPV cervical histopathology but not recurrence/relapse after LEEP in ART-suppressed HIV+HPV+ women. Carcinogenesis. 2019 04 29; 40(2):225-233.
    View in: PubMed
    Score: 0,016
  33. Discordant rifampicin susceptibility results are associated with Xpert® MTB/RIF probe B and probe binding delay. Int J Tuberc Lung Dis. 2019 03 01; 23(3):358-362.
    View in: PubMed
    Score: 0,015
  34. The relationship between menopausal women infected with the human immunodeficiency virus and cervical atrophy: A cytologic study. Diagn Cytopathol. 2019 Apr; 47(4):302-306.
    View in: PubMed
    Score: 0,015
  35. Cost-Effectiveness of Cervical Cancer Screening in Women Living With HIV in South Africa: A Mathematical Modeling Study. J Acquir Immune Defic Syndr. 2018 10 01; 79(2):195-205.
    View in: PubMed
    Score: 0,015
  36. Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1. Papillomavirus Res. 2018 12; 6:15-21.
    View in: PubMed
    Score: 0,015
  37. Can patients afford the cost of treatment for multidrug-resistant tuberculosis in Ethiopia? Int J Tuberc Lung Dis. 2018 08 01; 22(8):358-362.
    View in: PubMed
    Score: 0,015
  38. Age Differences by Sex in Antiretroviral-Naïve Participants: Pooled Analysis from Randomized Clinical Trials. J Assoc Nurses AIDS Care. 2018 May - Jun; 29(3):371-382.
    View in: PubMed
    Score: 0,014
  39. Persistently high early mortality despite rapid diagnostics for drug-resistant tuberculosis cases in South Africa. Int J Tuberc Lung Dis. 2017 10 01; 21(10):1106-1111.
    View in: PubMed
    Score: 0,014
  40. Prevalence of Anal Human Papillomavirus (HPV) and Performance of Cepheid Xpert and Hybrid Capture 2 (hc2) HPV Assays in South African HIV-Infected Women. Am J Clin Pathol. 2017 Aug 01; 148(2):148-153.
    View in: PubMed
    Score: 0,014
  41. Prevalence of Anal HPV and Anal Dysplasia in HIV-Infected Women From Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2017 07 01; 75(3):e59-e64.
    View in: PubMed
    Score: 0,014
  42. Cervical cancer risk and impact of Pap-based screening in HIV-positive women on antiretroviral therapy in Johannesburg, South Africa. Int J Cancer. 2017 08 01; 141(3):488-496.
    View in: PubMed
    Score: 0,014
  43. Herpes Simplex Virus Type 2 Acquisition Among HIV-1-Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study. J Infect Dis. 2017 03 15; 215(6):907-910.
    View in: PubMed
    Score: 0,013
  44. Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study. BMC Infect Dis. 2016 Oct 21; 16(1):593.
    View in: PubMed
    Score: 0,013
  45. Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342). J Antimicrob Chemother. 2016 06; 71(6):1609-18.
    View in: PubMed
    Score: 0,012
  46. Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings. Clin Infect Dis. 2016 May 01; 62(9):1081-8.
    View in: PubMed
    Score: 0,012
  47. International neurocognitive normative study: neurocognitive comparison data in diverse resource-limited settings: AIDS Clinical Trials Group A5271. J Neurovirol. 2016 08; 22(4):472-8.
    View in: PubMed
    Score: 0,012
  48. Anal dysplasia in HIV-infected women: a commentary on the field. Int J STD AIDS. 2017 May; 28(6):543-549.
    View in: PubMed
    Score: 0,012
  49. Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women. Clin Infect Dis. 2014 Jul 01; 59(1):127-35.
    View in: PubMed
    Score: 0,011
  50. Evaluation of two line probe assays for rapid detection of Mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB Mycobacteria in HIV-infected individuals with suspected TB. J Clin Microbiol. 2014 Apr; 52(4):1052-9.
    View in: PubMed
    Score: 0,011
  51. Improving diagnostic capability for HPV disease internationally within the NIH-NIAID Division of AIDS Clinical Trial Networks. Am J Clin Pathol. 2013 Dec; 140(6):881-9.
    View in: PubMed
    Score: 0,011
  52. Incidence and progression of cervical lesions in women with HIV: a systematic global review. Int J STD AIDS. 2014 Mar; 25(3):163-77.
    View in: PubMed
    Score: 0,011
  53. Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings. PLoS Med. 2012; 9(8):e1001290.
    View in: PubMed
    Score: 0,010
  54. Effect of trichomoniasis therapy on genital HIV viral burden among African women. Sex Transm Dis. 2012 Aug; 39(8):638-42.
    View in: PubMed
    Score: 0,010
  55. Antiretroviral therapy interruptions result in loss of protective humoral immunity to neoantigens in HIV-infected individuals. AIDS. 2012 Jul 17; 26(11):1355-62.
    View in: PubMed
    Score: 0,010
  56. Metabolic and anthropometric parameters contribute to ART-mediated CD4+ T cell recovery in HIV-1-infected individuals: an observational study. J Int AIDS Soc. 2011 Jul 29; 14:37.
    View in: PubMed
    Score: 0,009
  57. Bacterial vaginosis as a risk factor for high-grade cervical lesions and cancer in HIV-seropositive women. Int J Gynaecol Obstet. 2011 Sep; 114(3):273-7.
    View in: PubMed
    Score: 0,009
  58. Association between HIV replication and serum leptin levels: an observational study of a cohort of HIV-1-infected South African women. J Int AIDS Soc. 2010 Sep 07; 13:33.
    View in: PubMed
    Score: 0,009
  59. Complex regional pain syndrome in a HIV seropositive patient starting antiretroviral therapy. J Clin Rheumatol. 2009 Oct; 15(7):371-2.
    View in: PubMed
    Score: 0,008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.